_id
6911b824ccc777a4e85d60c1
Ticker
FULC
Name
Fulcrum Therapeutics Inc
Exchange
NASDAQ
Address
26 Landsdowne Street, Cambridge, MA, United States, 02139
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.fulcrumtx.com
Description
Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops small molecules to improve the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its clinical-stage product candidate is pociredir, a fetal hemoglobin inducer, which is in phase 1b clinical trial for the treatment of sickle cell disease and beta-thalassemia. The company also discovers drug targets for potential treatment inherited aplastic anemias, such as of diamond-blackfan anemia, shwachman-diamond syndrome, and fanconi anemia, as well as novel fetal hemoglobin inducers, fibrotic disorders, and cardiomyopathies which is in preclinical trial. It has collaboration and license agreement with MyoKardia, Inc. to identify biological targets that are capable of modulating genes of interest with relevance to cardiomyopathies; and licensce agreement with CAMP4 which includes certain small molecule compounds, composition of matter and method of use patent rights, and know-how to research, develop, manufacture, use, and commercialize; and Sanofi for the development and commercialization of losmapimod, an oral small molecule being investigated for the treatment of facioscapulohumeral muscular dystrophy. Fulcrum Therapeutics, Inc. was Incorporated in 2015 and is headquartered in Cambridge, Massachusetts.
Last Close
12.8
Volume
326308
Current Price
12.89
Change
0.7031249999999989
Last Updated
2025-11-30T19:07:29.690Z
Image
data:image/webp;base64,UklGRmQGAABXRUJQVlA4WAoAAAAQAAAAPwAAPwAAQUxQSDcDAAABoAXbtmnbGXOu2LadXMS2bdu2bdu2bdu282zb75295hwfe5991jk7+oyICcD/nyISQqiKhiCoquYBTDX3LB2333PdHJBWAyBo33/7qwf1HEqOWRzaYjMsuuBlLz3ajU6SGYcs0mIBu0wcGkm3QufwVhPM8TmzGJ2FzhGtBsXjzFjfOawCzzCWMF4CQas9VSrycISWe6GU8cgK7DyJXi/y+AosNLyEc9hG0BYTLNClROQHELR6wMmMdZwXVmKXzL3A2XNhaMtB8DazgoxnI6AKq/VgFmPM2G0+SAWgWKk3jbTxJ0FQyYDVn336qefvWCqgyaLJpxIUBk1fUHXBnB0rtCVvz7el71gMQMAJHD+pmuP5OSABpzCymsbHAAScxMwraaytDEXAqYyspLO2SsGRtKpwTSgE03/N6OWb4OUjf1wIAgCfMLKKkRciAAJ83kiMZdy9TM0auTIHoHPDddcruf6aW/WiFXkkPVqR8Y3V11+v7LobLgopKC+Y5nE6C81YmxjpXuC0k6BIqqWnxnasYxz/+saLHvJ+d8YcjT0XxlRaVuqUVqwyiM585GtbAlC0dWXM0fjxAhA0V3EjI/PG52aCqmpAWxdajpEPQ5ujOInGvPHZGTEV8gHtf9ByzpFrQ5shmOf7IuOABRBQPBW2o+dovBtNVRxFI0nnpGOgqCuY/n56zjl6ZWg6wQy/FkU+DUVJwVy96SQZeX8zFMsPopN0TlyvHAJOZ8w5x6wBbcJtjCQZ+XiAlBIs8ieNJI0PKiSRon0UnaRzwmYIKK+4oF63mZIBd9FI0vgcFI2K3EEj6azthZBGoD8WOGvrJgg4kpEkje/NAkmi2HMSnWTkYwJpSLBoFxpJOjdESBJwITOSzpGbQNG44iw6SaevA02hWKQLnaTxe0FKRVuNTtL4LJIqVskKnBdDUghmfZ1W8Mu0kASChxhJOrkWQgpMhXOZkaTZ4QgJgM+YmVnGd+eEJFGs0Z/RzDJemujcV0fSmfFaBCQV4DsanV1e2AWaBNh03x2fG/7T2pA0EBzRv99vh+zdAUFaVQDTzz0LmqhzzDUbAE0FhBAEkGYA0KBoqoigmSKC/x0BAFZQOCAGAwAAUBAAnQEqQABAAD6lQJxJpiOjITH8bbDAFIlsDbWlXS4J8r5mChPbvyA5nznMz4hAbYjzAedd/SfUn/it8A9ADpMv7f/3fS5aMi31Az7cXoDfCJMVPA2FqzJm/HgAaDeGR4KtmwCX5mTn8ce3E/15Z/TLrOnspfvVE0COVVyjMXBLLN13MAn84qGHYAD+/TZxJi8H39Q6P/04ic+ylVd4kmdJ3SPZ2ERLnbjHudabPkYvKEiHJ0LafYm3i2DA7hIi3knstod2nNW2HAXf/OwBlwBeTulUHrd4zHatQhDj2jnHypjlDcJQKhDgJZzP/zpLK5Mrkx7bSIj2A9Fm7/MvFnZKS/wLmxVa6ZHoq5cqsP8KDP7NqSgK3+cBgsRwL2f8vaKZhLzWmxc/vcwVcaoQUNb6jxTTRoHh2rH9APYxVfeWUdySGBF7NeNuGlKlHLrbn/s3CMa77XOGSYH6vDqaydRK6xLdKc3tHoAL3Bh+/tF+j/g3fIXFHKHu8KZ31xPmj/gm6t2u+FAEnjG7fRooe3yTMzOUkCGDG1zZtDvpHe4/kB79JJ+mmn7cuCvnUcrRrbGoepjTjjNyuqp7fm2iZJEjMj4V86J24/4FINPyHySyTJP1/IP5dqsW2ES99i8egAC+ofsszR2aocDSGfbVskHAZxm+c7me9dZgBT8w7Q9MDN1/U9laZam16+e4HmtoMVeHdPVcQ+qCOGvZD+a+MYecVwoEI7vVDN9odgcNBvTsBXegz0bfFUTXsRM/elc9TRtPv+qMr1TP+Bn41MxdEka4wMfyd48tvrlbOBeA4i9umm8f/FlPvjUDmBbvsrogc1h1GU6N7D7ksfkXOzRakHKGb4vxXj1QGe5A+Ty2NRGwhLnCFFPlKP/SxaecdIh9T4Bn+HTpDSTiuJJgy/Abj9efyzqOJUSDnM2g5G7VvIHS3hU3AP/jb4pdOtT2Etuuk5VV1Yl7EOveV9Oy+mZbTilh0Ena89uTDHONgCPLJuV1JZUdY8T6Hn+7LiGBGBt8i5sKBgAA
Ipo Date
2019-07-18T00:00:00.000Z
Market Cap
592055680
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.76
Sentiment Sources
4
Rating
3.5714
Target Price
14.5556
Strong Buy
2
Buy
1
Hold
3
Sell
1
Strong Sell
0
Current Quarter
2025-09-30
Revenue
0
Cost Of Revenue
-
Gross Profit
-
Operating Expenses
21858000
Operating Income
-21858000
Interest Expense
-
Pretax Income
-19595000
Net Income
-19595000
Eps
-0.31303417096665975
Dividends Per Share
-
Shares Outstanding
54118438
Income Tax Expense
-
EBITDA
-19249000
Operating Margin
-
Total Other Income Expense Net
2263000
Cash
47078000
Short Term Investments
153567000
Receivables
-
Inventories
-
Total Current Assets
205863000
Property Plant Equipment
7785000
Total Assets
214858000
Payables
2856000
Short Term Debt
2348000
Long Term Debt
-
Total Liabilities
16492000
Equity
198366000
Depreciation
300000
Change In Working Capital
2285000
Cash From Operations
-14190000
Capital Expenditures
90000
Cash From Investing
18612000
Cash From Financing
64000
Net Change In Cash
4490000
PE
-
PB
4.067609015657926
ROE
-9.87820493431334
ROA
-9.119976914985712
FCF
-14280000
Fcf Percent
-
Piotroski FScore
1
Health Score
38
Deep Value Investing Score
3
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
3.8
Garp Investing Score
2
Growth Investing Score
0.5
Momentum Investing Score
2.5
Net Net Investing Score
2.5
Quality Investing Score
2.5
Value Investing Score
3.5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
-
Quarters > 0 > income Statement > operating Expenses
21858000
Quarters > 0 > income Statement > operating Income
-21858000
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-19595000
Quarters > 0 > income Statement > net Income
-19595000
Quarters > 0 > income Statement > eps
-0.31303417096665975
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
62597000
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-19249000
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
2263000
Quarters > 0 > balance Sheet > cash
47078000
Quarters > 0 > balance Sheet > short Term Investments
153567000
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
205863000
Quarters > 0 > balance Sheet > property Plant Equipment
7785000
Quarters > 0 > balance Sheet > total Assets
214858000
Quarters > 0 > balance Sheet > payables
2856000
Quarters > 0 > balance Sheet > short Term Debt
2348000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
16492000
Quarters > 0 > balance Sheet > equity
198366000
Quarters > 0 > cash Flow > net Income
-19595000
Quarters > 0 > cash Flow > depreciation
300000
Quarters > 0 > cash Flow > change In Working Capital
2285000
Quarters > 0 > cash Flow > cash From Operations
-14190000
Quarters > 0 > cash Flow > capital Expenditures
90000
Quarters > 0 > cash Flow > cash From Investing
18612000
Quarters > 0 > cash Flow > cash From Financing
64000
Quarters > 0 > cash Flow > net Change In Cash
4490000
Quarters > 0 > ratios > PE
-0.31303417096665975
Quarters > 0 > ratios > PB
4.067609015657926
Quarters > 0 > ratios > ROE
-9.87820493431334
Quarters > 0 > ratios > ROA
-9.119976914985712
Quarters > 0 > ratios > FCF
-14280000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
38
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
300000
Quarters > 1 > income Statement > gross Profit
-300000
Quarters > 1 > income Statement > operating Expenses
19515000
Quarters > 1 > income Statement > operating Income
-19815000
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-17296000
Quarters > 1 > income Statement > net Income
-17296000
Quarters > 1 > income Statement > eps
-0.27654131491430034
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
62544000
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-16952000
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
2519000
Quarters > 1 > balance Sheet > cash
42588000
Quarters > 1 > balance Sheet > short Term Investments
171523000
Quarters > 1 > balance Sheet > receivables
1334000
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
219373000
Quarters > 1 > balance Sheet > property Plant Equipment
8248000
Quarters > 1 > balance Sheet > total Assets
228838000
Quarters > 1 > balance Sheet > payables
1751000
Quarters > 1 > balance Sheet > short Term Debt
2293000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
14460000
Quarters > 1 > balance Sheet > equity
214378000
Quarters > 1 > cash Flow > net Income
-17296000
Quarters > 1 > cash Flow > depreciation
344000
Quarters > 1 > cash Flow > change In Working Capital
1342000
Quarters > 1 > cash Flow > cash From Operations
-13820000
Quarters > 1 > cash Flow > capital Expenditures
65000
Quarters > 1 > cash Flow > cash From Investing
13933000
Quarters > 1 > cash Flow > cash From Financing
301000
Quarters > 1 > cash Flow > net Change In Cash
414000
Quarters > 1 > ratios > PE
-0.27654131491430034
Quarters > 1 > ratios > PB
3.7606105104068517
Quarters > 1 > ratios > ROE
-8.067992051423186
Quarters > 1 > ratios > ROA
-7.558185266433022
Quarters > 1 > ratios > FCF
-13885000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
38
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
0
Quarters > 2 > income Statement > cost Of Revenue
-
Quarters > 2 > income Statement > gross Profit
-
Quarters > 2 > income Statement > operating Expenses
20403000
Quarters > 2 > income Statement > operating Income
-20403000
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-17655000
Quarters > 2 > income Statement > net Income
-17655000
Quarters > 2 > income Statement > eps
-0.282574945181581
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
62479000
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-20050000
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
2748000
Quarters > 2 > balance Sheet > cash
42178000
Quarters > 2 > balance Sheet > short Term Investments
184425000
Quarters > 2 > balance Sheet > receivables
979000
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
232556000
Quarters > 2 > balance Sheet > property Plant Equipment
8882000
Quarters > 2 > balance Sheet > total Assets
242649000
Quarters > 2 > balance Sheet > payables
1507000
Quarters > 2 > balance Sheet > short Term Debt
2239000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
14163000
Quarters > 2 > balance Sheet > equity
228486000
Quarters > 2 > cash Flow > net Income
-17655000
Quarters > 2 > cash Flow > depreciation
353000
Quarters > 2 > cash Flow > change In Working Capital
-223000
Quarters > 2 > cash Flow > cash From Operations
-15257000
Quarters > 2 > cash Flow > capital Expenditures
0
Quarters > 2 > cash Flow > cash From Investing
-777000
Quarters > 2 > cash Flow > cash From Financing
0
Quarters > 2 > cash Flow > net Change In Cash
-16034000
Quarters > 2 > ratios > PE
-0.282574945181581
Quarters > 2 > ratios > PB
3.5247424787514334
Quarters > 2 > ratios > ROE
-7.7269504477298385
Quarters > 2 > ratios > ROA
-7.275941792465661
Quarters > 2 > ratios > FCF
-15257000
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
38
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
0
Quarters > 3 > income Statement > cost Of Revenue
369000
Quarters > 3 > income Statement > gross Profit
-369000
Quarters > 3 > income Statement > operating Expenses
19060000
Quarters > 3 > income Statement > operating Income
-19429000
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-16568000
Quarters > 3 > income Statement > net Income
-16568000
Quarters > 3 > income Statement > eps
-0.30707639841346335
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
53954000
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-16199000
Quarters > 3 > income Statement > operating Margin
-
Quarters > 3 > income Statement > total Other Income Expense Net
2860999
Quarters > 3 > balance Sheet > cash
58212000
Quarters > 3 > balance Sheet > short Term Investments
182809000
Quarters > 3 > balance Sheet > receivables
3342000
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
249923000
Quarters > 3 > balance Sheet > property Plant Equipment
9584000
Quarters > 3 > balance Sheet > total Assets
260718000
Quarters > 3 > balance Sheet > payables
1164000
Quarters > 3 > balance Sheet > short Term Debt
2186000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
17684000
Quarters > 3 > balance Sheet > equity
243034000
Quarters > 3 > cash Flow > net Income
-16568000
Quarters > 3 > cash Flow > depreciation
369000
Quarters > 3 > cash Flow > change In Working Capital
-2094000
Quarters > 3 > cash Flow > cash From Operations
-16761000
Quarters > 3 > cash Flow > capital Expenditures
231000
Quarters > 3 > cash Flow > cash From Investing
2260000
Quarters > 3 > cash Flow > cash From Financing
83000
Quarters > 3 > cash Flow > net Change In Cash
-14418000
Quarters > 3 > ratios > PE
-0.30707639841346335
Quarters > 3 > ratios > PB
2.861603973106644
Quarters > 3 > ratios > ROE
-6.817153155525564
Quarters > 3 > ratios > ROA
-6.354758781518729
Quarters > 3 > ratios > FCF
-16992000
Quarters > 3 > ratios > Piotroski FScore
0
Quarters > 3 > ratios > fcf Percent
-
Quarters > 3 > health Score
42
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
80000000
Annuals > 0 > income Statement > cost Of Revenue
63386000
Annuals > 0 > income Statement > gross Profit
16614000
Annuals > 0 > income Statement > operating Expenses
38511000
Annuals > 0 > income Statement > operating Income
-21897000
Annuals > 0 > income Statement > interest Expense
-
Annuals > 0 > income Statement > pretax Income
-9725000
Annuals > 0 > income Statement > net Income
-9725000
Annuals > 0 > income Statement > eps
-0.15689532782653587
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
61984000
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-18241000
Annuals > 0 > income Statement > operating Margin
-27.371250000000003
Annuals > 0 > income Statement > total Other Income Expense Net
12172000
Annuals > 0 > balance Sheet > cash
58212000
Annuals > 0 > balance Sheet > short Term Investments
182809000
Annuals > 0 > balance Sheet > receivables
3342000
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
249923000
Annuals > 0 > balance Sheet > property Plant Equipment
9584000
Annuals > 0 > balance Sheet > total Assets
260718000
Annuals > 0 > balance Sheet > payables
1164000
Annuals > 0 > balance Sheet > short Term Debt
2186000
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
17684000
Annuals > 0 > balance Sheet > equity
243034000
Annuals > 0 > cash Flow > net Income
-9725000
Annuals > 0 > cash Flow > depreciation
1593000
Annuals > 0 > cash Flow > change In Working Capital
-4248000
Annuals > 0 > cash Flow > cash From Operations
-2218000
Annuals > 0 > cash Flow > capital Expenditures
278000
Annuals > 0 > cash Flow > cash From Investing
32230000
Annuals > 0 > cash Flow > cash From Financing
2746000
Annuals > 0 > cash Flow > net Change In Cash
32758000
Annuals > 0 > ratios > PE
-0.15689532782653587
Annuals > 0 > ratios > PB
2.7901649974900633
Annuals > 0 > ratios > ROE
-4.001497732827505
Annuals > 0 > ratios > ROA
-3.7300838453808325
Annuals > 0 > ratios > FCF
-2496000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-0.0312
Annuals > 0 > health Score
34
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
2805000
Annuals > 1 > income Statement > cost Of Revenue
71801000
Annuals > 1 > income Statement > gross Profit
2805000
Annuals > 1 > income Statement > operating Expenses
113469000
Annuals > 1 > income Statement > operating Income
-110664000
Annuals > 1 > income Statement > interest Expense
-
Annuals > 1 > income Statement > pretax Income
-97335000
Annuals > 1 > income Statement > net Income
-97335000
Annuals > 1 > income Statement > eps
-1.5875876692219866
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
61310000
Annuals > 1 > income Statement > income Tax Expense
2004105
Annuals > 1 > income Statement > EBITDA
-108492000
Annuals > 1 > income Statement > operating Margin
-3945.24064171123
Annuals > 1 > income Statement > total Other Income Expense Net
13329000
Annuals > 1 > balance Sheet > cash
25563000
Annuals > 1 > balance Sheet > short Term Investments
210658000
Annuals > 1 > balance Sheet > receivables
2249000
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
242199000
Annuals > 1 > balance Sheet > property Plant Equipment
12392000
Annuals > 1 > balance Sheet > total Assets
257694000
Annuals > 1 > balance Sheet > payables
2757000
Annuals > 1 > balance Sheet > short Term Debt
2192000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
22501000
Annuals > 1 > balance Sheet > equity
235193000
Annuals > 1 > cash Flow > net Income
-97335000
Annuals > 1 > cash Flow > depreciation
2172000
Annuals > 1 > cash Flow > change In Working Capital
-4613000
Annuals > 1 > cash Flow > cash From Operations
-90965000
Annuals > 1 > cash Flow > capital Expenditures
508000
Annuals > 1 > cash Flow > cash From Investing
-36692000
Annuals > 1 > cash Flow > cash From Financing
118122000
Annuals > 1 > cash Flow > net Change In Cash
-9535000
Annuals > 1 > ratios > PE
-1.5875876692219866
Annuals > 1 > ratios > PB
2.8518340256725327
Annuals > 1 > ratios > ROE
-41.38516027262716
Annuals > 1 > ratios > ROA
-37.771542992851984
Annuals > 1 > ratios > FCF
-91473000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-32.610695187165774
Annuals > 1 > health Score
34
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
6342000
Annuals > 2 > income Statement > cost Of Revenue
76782000
Annuals > 2 > income Statement > gross Profit
-70440000
Annuals > 2 > income Statement > operating Expenses
42121000
Annuals > 2 > income Statement > operating Income
-112561000
Annuals > 2 > income Statement > interest Expense
2690000
Annuals > 2 > income Statement > pretax Income
-109871000
Annuals > 2 > income Statement > net Income
-109871000
Annuals > 2 > income Statement > eps
-2.442066191015981
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
44991000
Annuals > 2 > income Statement > income Tax Expense
-4250000
Annuals > 2 > income Statement > EBITDA
-109720000
Annuals > 2 > income Statement > operating Margin
-1774.8502049826552
Annuals > 2 > income Statement > total Other Income Expense Net
2690000
Annuals > 2 > balance Sheet > cash
35098000
Annuals > 2 > balance Sheet > short Term Investments
167823000
Annuals > 2 > balance Sheet > receivables
1081000
Annuals > 2 > balance Sheet > inventories
-473000
Annuals > 2 > balance Sheet > total Current Assets
207519000
Annuals > 2 > balance Sheet > property Plant Equipment
15969000
Annuals > 2 > balance Sheet > total Assets
226685000
Annuals > 2 > balance Sheet > payables
3638000
Annuals > 2 > balance Sheet > short Term Debt
2602000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
27743000
Annuals > 2 > balance Sheet > equity
198942000
Annuals > 2 > cash Flow > net Income
-109872000
Annuals > 2 > cash Flow > depreciation
2414000
Annuals > 2 > cash Flow > change In Working Capital
-3094000
Annuals > 2 > cash Flow > cash From Operations
-97050000
Annuals > 2 > cash Flow > capital Expenditures
1963000
Annuals > 2 > cash Flow > cash From Investing
12413000
Annuals > 2 > cash Flow > cash From Financing
84323000
Annuals > 2 > cash Flow > net Change In Cash
-314000
Annuals > 2 > ratios > PE
-2.442066191015981
Annuals > 2 > ratios > PB
2.474095666073529
Annuals > 2 > ratios > ROE
-55.227654291200444
Annuals > 2 > ratios > ROA
-48.46857974722633
Annuals > 2 > ratios > FCF
-99013000
Annuals > 2 > ratios > Piotroski FScore
1
Annuals > 2 > ratios > fcf Percent
-15.6122674235257
Annuals > 2 > health Score
35
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
19163000
Annuals > 3 > income Statement > cost Of Revenue
2515000
Annuals > 3 > income Statement > gross Profit
19163000
Annuals > 3 > income Statement > operating Expenses
100217000
Annuals > 3 > income Statement > operating Income
-81054000
Annuals > 3 > income Statement > interest Expense
2722000
Annuals > 3 > income Statement > pretax Income
-80847000
Annuals > 3 > income Statement > net Income
-78332000
Annuals > 3 > income Statement > eps
-2.215208845903679
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
35361000
Annuals > 3 > income Statement > income Tax Expense
-2515000
Annuals > 3 > income Statement > EBITDA
-78539000
Annuals > 3 > income Statement > operating Margin
-422.9713510410687
Annuals > 3 > income Statement > total Other Income Expense Net
207000
Annuals > 3 > balance Sheet > cash
35412000
Annuals > 3 > balance Sheet > short Term Investments
182750000
Annuals > 3 > balance Sheet > receivables
4110000
Annuals > 3 > balance Sheet > inventories
-473000
Annuals > 3 > balance Sheet > total Current Assets
225998000
Annuals > 3 > balance Sheet > property Plant Equipment
7368000
Annuals > 3 > balance Sheet > total Assets
235000000
Annuals > 3 > balance Sheet > payables
4788000
Annuals > 3 > balance Sheet > short Term Debt
9626000
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
23461000
Annuals > 3 > balance Sheet > equity
211539000
Annuals > 3 > cash Flow > net Income
-80847000
Annuals > 3 > cash Flow > depreciation
2515000
Annuals > 3 > cash Flow > change In Working Capital
-11889000
Annuals > 3 > cash Flow > cash From Operations
-78478000
Annuals > 3 > cash Flow > capital Expenditures
1713000
Annuals > 3 > cash Flow > cash From Investing
-129669000
Annuals > 3 > cash Flow > cash From Financing
186507000
Annuals > 3 > cash Flow > net Change In Cash
-21640000
Annuals > 3 > ratios > PE
-2.215208845903679
Annuals > 3 > ratios > PB
1.8287376795768155
Annuals > 3 > ratios > ROE
-37.02957847016389
Annuals > 3 > ratios > ROA
-33.33276595744681
Annuals > 3 > ratios > FCF
-80191000
Annuals > 3 > ratios > Piotroski FScore
1
Annuals > 3 > ratios > fcf Percent
-4.1846788081198145
Annuals > 3 > health Score
35
Valuation > metrics > PE
-0.31303417096665975
Valuation > metrics > PB
4.067609015657926
Valuation > final Score
39.32390984342074
Valuation > verdict
35.6% Overvalued
Profitability > metrics > ROE
-9.87820493431334
Profitability > metrics > ROA
-9.518466164390881
Profitability > final Score
15
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.08313924765332768
Risk > metrics > Interest Coverage
-63.17341040462428
Risk > final Score
-193
Risk > verdict
High
Liquidity > metrics > Current Ratio
39.558608762490394
Liquidity > metrics > Quick Ratio
39.558608762490394
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
42.39389489593148
Prev Valuations > 1
44.75257521248567
Prev Valuations > 2
80
Prev Profitabilities > 0
15
Prev Profitabilities > 1
15
Prev Profitabilities > 2
15
Prev Risks > 0
-170
Prev Risks > 1
26
Prev Risks > 2
-151
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2025-12-13T00:42:51.105Z
Earnings History > 0 > period
2025-12-31
Earnings History > 0 > report Date
2026-02-26
Earnings History > 0 > date
2025-12-31
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
0
Earnings History > 0 > eps Estimate
-0.31
Earnings History > 0 > eps Difference
0.31
Earnings History > 0 > surprise Percent
100
Earnings History > 1 > period
2025-09-30
Earnings History > 1 > report Date
2025-10-29
Earnings History > 1 > date
2025-09-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.31
Earnings History > 1 > eps Estimate
-0.29
Earnings History > 1 > eps Difference
-0.02
Earnings History > 1 > surprise Percent
-6.8966
Earnings History > 2 > period
2025-06-30
Earnings History > 2 > report Date
2025-07-29
Earnings History > 2 > date
2025-06-30
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.28
Earnings History > 2 > eps Estimate
-0.29
Earnings History > 2 > eps Difference
0.01
Earnings History > 2 > surprise Percent
3.4483
Earnings History > 3 > period
2025-03-31
Earnings History > 3 > report Date
2025-05-12
Earnings History > 3 > date
2025-03-31
Earnings History > 3 > before After Market
BeforeMarket
Earnings History > 3 > currency
USD
Earnings History > 3 > eps Actual
-0.28
Earnings History > 3 > eps Estimate
-0.325
Earnings History > 3 > eps Difference
0.045
Earnings History > 3 > surprise Percent
13.8462
Earnings History > 4 > period
2024-12-31
Earnings History > 4 > report Date
2025-02-25
Earnings History > 4 > date
2024-12-31
Earnings History > 4 > before After Market
BeforeMarket
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-0.31
Earnings History > 4 > eps Estimate
-0.2883
Earnings History > 4 > eps Difference
-0.0217
Earnings History > 4 > surprise Percent
-7.5269
Earnings History > 5 > period
2024-09-30
Earnings History > 5 > report Date
2024-11-05
Earnings History > 5 > date
2024-09-30
Earnings History > 5 > before After Market
BeforeMarket
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.4633
Earnings History > 5 > eps Estimate
-0.41
Earnings History > 5 > eps Difference
-0.0533
Earnings History > 5 > surprise Percent
-13
Earnings History > 6 > period
2024-06-30
Earnings History > 6 > report Date
2024-07-31
Earnings History > 6 > date
2024-06-30
Earnings History > 6 > before After Market
BeforeMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
0.87
Earnings History > 6 > eps Estimate
-0.01
Earnings History > 6 > eps Difference
0.88
Earnings History > 6 > surprise Percent
8800
Earnings History > 7 > period
2024-03-31
Earnings History > 7 > report Date
2024-05-13
Earnings History > 7 > date
2024-03-31
Earnings History > 7 > before After Market
BeforeMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.43
Earnings History > 7 > eps Estimate
-0.44
Earnings History > 7 > eps Difference
0.01
Earnings History > 7 > surprise Percent
2.2727
Earnings History > 8 > period
2023-12-31
Earnings History > 8 > report Date
2024-02-27
Earnings History > 8 > date
2023-12-31
Earnings History > 8 > before After Market
BeforeMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.4
Earnings History > 8 > eps Estimate
-0.43
Earnings History > 8 > eps Difference
0.03
Earnings History > 8 > surprise Percent
6.9767
Earnings History > 9 > period
2023-09-30
Earnings History > 9 > report Date
2023-11-07
Earnings History > 9 > date
2023-09-30
Earnings History > 9 > before After Market
BeforeMarket
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.39
Earnings History > 9 > eps Estimate
-0.43
Earnings History > 9 > eps Difference
0.04
Earnings History > 9 > surprise Percent
9.3023
Earnings History > 10 > period
2023-06-30
Earnings History > 10 > report Date
2023-08-03
Earnings History > 10 > date
2023-06-30
Earnings History > 10 > before After Market
BeforeMarket
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.38
Earnings History > 10 > eps Estimate
-0.44
Earnings History > 10 > eps Difference
0.06
Earnings History > 10 > surprise Percent
13.6364
Earnings History > 11 > period
2023-03-31
Earnings History > 11 > report Date
2023-05-15
Earnings History > 11 > date
2023-03-31
Earnings History > 11 > before After Market
BeforeMarket
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.41
Earnings History > 11 > eps Estimate
-0.46
Earnings History > 11 > eps Difference
0.05
Earnings History > 11 > surprise Percent
10.8696
Earnings History > 12 > period
2022-12-31
Earnings History > 12 > report Date
2023-03-09
Earnings History > 12 > date
2022-12-31
Earnings History > 12 > before After Market
BeforeMarket
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.5
Earnings History > 12 > eps Estimate
-0.49
Earnings History > 12 > eps Difference
-0.01
Earnings History > 12 > surprise Percent
-2.0408
Earnings History > 13 > period
2022-09-30
Earnings History > 13 > report Date
2022-11-08
Earnings History > 13 > date
2022-09-30
Earnings History > 13 > before After Market
BeforeMarket
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-0.51
Earnings History > 13 > eps Estimate
-0.61
Earnings History > 13 > eps Difference
0.1
Earnings History > 13 > surprise Percent
16.3934
Earnings History > 14 > period
2022-06-30
Earnings History > 14 > report Date
2022-08-11
Earnings History > 14 > date
2022-06-30
Earnings History > 14 > before After Market
BeforeMarket
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-0.83
Earnings History > 14 > eps Estimate
-0.66
Earnings History > 14 > eps Difference
-0.17
Earnings History > 14 > surprise Percent
-25.7576
Earnings History > 15 > period
2022-03-31
Earnings History > 15 > report Date
2022-05-09
Earnings History > 15 > date
2022-03-31
Earnings History > 15 > before After Market
BeforeMarket
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-0.64
Earnings History > 15 > eps Estimate
-0.63
Earnings History > 15 > eps Difference
-0.01
Earnings History > 15 > surprise Percent
-1.5873
Earnings History > 16 > period
2021-12-31
Earnings History > 16 > report Date
2022-03-03
Earnings History > 16 > date
2021-12-31
Earnings History > 16 > before After Market
BeforeMarket
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
-0.58
Earnings History > 16 > eps Estimate
-0.73
Earnings History > 16 > eps Difference
0.15
Earnings History > 16 > surprise Percent
20.5479
Earnings History > 17 > period
2021-09-30
Earnings History > 17 > report Date
2021-11-04
Earnings History > 17 > date
2021-09-30
Earnings History > 17 > before After Market
BeforeMarket
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
-0.57
Earnings History > 17 > eps Estimate
-0.65
Earnings History > 17 > eps Difference
0.08
Earnings History > 17 > surprise Percent
12.3077
Earnings History > 18 > period
2021-06-30
Earnings History > 18 > report Date
2021-08-10
Earnings History > 18 > date
2021-06-30
Earnings History > 18 > before After Market
BeforeMarket
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
-0.6
Earnings History > 18 > eps Estimate
-0.62
Earnings History > 18 > eps Difference
0.02
Earnings History > 18 > surprise Percent
3.2258
Earnings History > 19 > period
2021-03-31
Earnings History > 19 > report Date
2021-05-06
Earnings History > 19 > date
2021-03-31
Earnings History > 19 > before After Market
BeforeMarket
Earnings History > 19 > currency
USD
Earnings History > 19 > eps Actual
-0.54
Earnings History > 19 > eps Estimate
-0.66
Earnings History > 19 > eps Difference
0.12
Earnings History > 19 > surprise Percent
18.1818
Earnings History > 20 > period
2020-12-31
Earnings History > 20 > report Date
2021-03-04
Earnings History > 20 > date
2020-12-31
Earnings History > 20 > before After Market
BeforeMarket
Earnings History > 20 > currency
USD
Earnings History > 20 > eps Actual
-0.64
Earnings History > 20 > eps Estimate
-0.72
Earnings History > 20 > eps Difference
0.08
Earnings History > 20 > surprise Percent
11.1111
Earnings History > 21 > period
2020-09-30
Earnings History > 21 > report Date
2020-11-10
Earnings History > 21 > date
2020-09-30
Earnings History > 21 > before After Market
BeforeMarket
Earnings History > 21 > currency
USD
Earnings History > 21 > eps Actual
-0.7
Earnings History > 21 > eps Estimate
-0.65
Earnings History > 21 > eps Difference
-0.05
Earnings History > 21 > surprise Percent
-7.6923
Earnings History > 22 > period
2020-06-30
Earnings History > 22 > report Date
2020-08-11
Earnings History > 22 > date
2020-06-30
Earnings History > 22 > before After Market
BeforeMarket
Earnings History > 22 > currency
USD
Earnings History > 22 > eps Actual
-0.66
Earnings History > 22 > eps Estimate
-0.78
Earnings History > 22 > eps Difference
0.12
Earnings History > 22 > surprise Percent
15.3846
Earnings History > 23 > period
2020-03-31
Earnings History > 23 > report Date
2020-05-13
Earnings History > 23 > date
2020-03-31
Earnings History > 23 > before After Market
BeforeMarket
Earnings History > 23 > currency
USD
Earnings History > 23 > eps Actual
-0.81
Earnings History > 23 > eps Estimate
-0.75
Earnings History > 23 > eps Difference
-0.06
Earnings History > 23 > surprise Percent
-8
Earnings History > 24 > period
2019-12-31
Earnings History > 24 > report Date
2020-03-05
Earnings History > 24 > date
2019-12-31
Earnings History > 24 > before After Market
BeforeMarket
Earnings History > 24 > currency
USD
Earnings History > 24 > eps Actual
-0.71
Earnings History > 24 > eps Estimate
-0.83
Earnings History > 24 > eps Difference
0.12
Earnings History > 24 > surprise Percent
14.4578
Earnings History > 25 > period
2019-09-30
Earnings History > 25 > report Date
2019-11-14
Earnings History > 25 > date
2019-09-30
Earnings History > 25 > before After Market
BeforeMarket
Earnings History > 25 > currency
USD
Earnings History > 25 > eps Actual
-0.97
Earnings History > 25 > eps Estimate
-2.98
Earnings History > 25 > eps Difference
2.01
Earnings History > 25 > surprise Percent
67.4497
Earnings History > 26 > period
2019-06-30
Earnings History > 26 > report Date
2019-08-26
Earnings History > 26 > date
2019-06-30
Earnings History > 26 > before After Market
BeforeMarket
Earnings History > 26 > currency
USD
Earnings History > 26 > eps Actual
-9.21
Earnings History > 26 > eps Estimate
-3.1
Earnings History > 26 > eps Difference
-6.11
Earnings History > 26 > surprise Percent
-197.0968
Earnings History > 27 > period
2019-03-31
Earnings History > 27 > report Date
2019-05-29
Earnings History > 27 > date
2019-03-31
Earnings History > 27 > before After Market
-
Earnings History > 27 > currency
USD
Earnings History > 27 > eps Actual
-0.31
Earnings History > 27 > eps Estimate
0
Earnings History > 27 > eps Difference
-0.31
Earnings History > 27 > surprise Percent
-
Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops small molecules to improve the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its clinical-stage product candidate is pociredir, a fetal hemoglobin inducer, which is in phase 1b clinical trial for the treatment of sickle cell disease and beta-thalassemia. The company also discovers drug targets for potential treatment inherited aplastic anemias, such as of diamond-blackfan anemia, shwachman-diamond syndrome, and fanconi anemia, as well as novel fetal hemoglobin inducers, fibrotic disorders, and cardiomyopathies which is in preclinical trial. It has collaboration and license agreement with MyoKardia, Inc. to identify biological targets that are capable of modulating genes of interest with relevance to cardiomyopathies; and licensce agreement with CAMP4 which includes certain small molecule compounds, composition of matter and method of use patent rights, and know-how to research, develop, manufacture, use, and commercialize; and Sanofi for the development and commercialization of losmapimod, an oral small molecule being investigated for the treatment of facioscapulohumeral muscular dystrophy. Fulcrum Therapeutics, Inc. was Incorporated in 2015 and is headquartered in Cambridge, Massachusetts.
Stock Price
$ 0.00
0% increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AFulcrum Therapeutics(FULC.US) 10% Shareholder Sells US$58.38 Million in Common Stock - 富途牛牛
12/11/2025
Fulcrum Therapeutics(FULC.US) 10% Shareholder Sells US$58.38 Million in Common Stock 富途牛牛
Read more →$FULC stock is down 8% today. Here's what we see in our data. Quiver Quantitative
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
BUY
Target Price:
$14.5556
Analyst Picks
Strong Buy
2
Buy
1
Hold
3
Sell
1
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 102.87% of the total shares of Fulcrum Therapeutics Inc
1.
RA Capital Management, LLC(18.9107%)
since
2025/06/30
2.
TCG Crossover Management, LLC(9.7058%)
since
2025/06/30
3.
Suvretta Capital Management, LLC(9.3968%)
since
2025/06/30
4.
Adage Capital Partners Gp LLC(8.4838%)
since
2025/06/30
5.
BlackRock Inc(8.0956%)
since
2025/06/30
6.
Nantahala Capital Management, LLC(7.9278%)
since
2025/06/30
7.
Vanguard Group Inc(5.8169%)
since
2025/06/30
8.
Vanguard Total Stock Mkt Idx Inv(3.3501%)
since
2025/07/31
9.
Dimensional Fund Advisors, Inc.(2.5376%)
since
2025/06/30
10.
Balyasny Asset Management LLC(2.474%)
since
2025/06/30
11.
iShares Russell 2000 ETF(2.4308%)
since
2025/08/31
12.
State Street Corp(2.2524%)
since
2025/06/30
13.
Geode Capital Management, LLC(2.2058%)
since
2025/06/30
14.
D. E. Shaw & Co LP(2.1754%)
since
2025/06/30
15.
Goldman Sachs Group Inc(2.1141%)
since
2025/06/30
16.
Woodline Partners LP(1.6594%)
since
2025/06/30
17.
Northern Trust Corp(1.1306%)
since
2025/06/30
18.
Fidelity Small Cap Index(0.9931%)
since
2025/06/30
19.
Point72 Asset Management, L.P.(0.9211%)
since
2025/06/30
20.
Amvescap Plc.(0.8695%)
since
2025/06/30
21.
Vanguard Institutional Extnd Mkt Idx Tr(0.8497%)
since
2025/07/31
22.
Exome Asset Management LLC(0.8226%)
since
2025/06/30
23.
Ikarian Capital, LLC(0.7922%)
since
2025/06/30
24.
iShares Russell 2000 Value ETF(0.7891%)
since
2025/08/31
25.
Charles Schwab Investment Management Inc(0.7169%)
since
2025/06/30
26.
Invesco Dorsey Wright SmallCap Momt ETF(0.6649%)
since
2025/08/29
27.
Vanguard Russell 2000 ETF(0.4704%)
since
2025/07/31
28.
Xtrackers S&P 500 2xLev Dly Swap ETF 1C(0.4627%)
since
2025/07/31
29.
State St Russell Sm Cap® Indx SL Cl I(0.4439%)
since
2025/08/31
30.
Fidelity Extended Market Index(0.4336%)
since
2025/07/31
31.
DFA US Small Cap I(0.4161%)
since
2025/07/31
32.
DFA US Micro Cap I(0.3766%)
since
2025/07/31
33.
Schwab US Small-Cap ETFâ„¢(0.3729%)
since
2025/08/30
34.
Dimensional US Small Cap ETF(0.2801%)
since
2025/08/29
35.
Dimensional US Targeted Value ETF(0.2642%)
since
2025/08/29
36.
abrdn Life Sciences Investors(0.2551%)
since
2025/08/31
37.
Northern Small Cap Value(0.2529%)
since
2025/06/30
38.
NT Quality Small Cap Value(0.2529%)
since
2025/06/30
39.
Schwab Small Cap Index(0.2513%)
since
2025/07/31
40.
Avantis US Small Cap Equity ETF(0.247%)
since
2025/08/30
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
-0.31
Date
2025-09-30
EPS Actual
-0.31
EPS Estimate
-0.29
EPS Difference
-0.02
Surprise Percent
-6.8966%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.